Effective diagnostics are usually developed over time. MARTI’s IP is founded in research out of the University of Pretoria. Details of relevant peer-reviewed publications are below.

Scientific publications

Schleicher, G.K., Feldman, C., Vermaak, Y., Verschoor, J.A., 2002. Prevalence of anti-mycolic acid antibodies in patients with pulmonary tuberculosis co-infected with HIV. Clinical Chemistry and Laboratory Medicine 40, 882-887.

Lemmer, Y., Thanyani, S.T., Vrey, P.J., Driver, C.H.S., Venter, L., van Wyngaardt, S., ten Bokum, A.M.C., Ozoemena, K.I., Pilcher, L.A., Fernig, D.G., Stoltz, A.C., Swai, H.S., Verschoor, J.A., Nejat, D., 2009. Chapter 5 Detection of antimycolic acid antibodies by liposomal biosensors, Methods in Enzymology. Academic Press, 79-104.

Ozoemena, K., Mathebula, N.S., Jeseelan, P., Toschi, G., Verschoor, J.A., 2010. Electron transfer dynamics across self-assembled N-(2-mercaptoethyl)octadecanamide/mycolic acid layers: impedimetric insights into the structural integrity and interaction with anti-mycolic acid antibodies. Physical Chemistry Chemical Physics 12, 345-357.

WHO publications

Commercial Serodiagnostic Tests for Diagnosis of Tuberculosis. Policy Statement

WHO Global Tuberculosis Report 2015

FIND publications

FIND Strategy for Tuberculosis 2015-2020

UNITAID publications

UNITAID TB Diagnostics Market in Select High-Burden Countries: Current Market and Future Opportunities for Novel Diagnostics

MARTI Downloads

MARTI brochure